New Delhi, Delhi
GST No. 07AAKFN5053A1ZK
Call 08048982480 93% Response Rate
Send Enquiry
Product Brochure
| Strength | 60 mg |
| Packaging Type | Pre-filled Syringe |
| Brand | Prolia |
| Manufacturer | DR REDDY'S LABORATORIES LTD |
| Packaging Size | 1 ml |
| Storage Temperature | 2-8 degree c |
| Shelf Life | 36 month |
| Composition | Denosumab |
Prolia 60mg Injection consists of the active ingredient Denosumab. It is mainly prescribed for treating osteoporosis, a condition characterized by weakened bones. Doctors also recommend Prolia injection for osteoporosis in postmenopausal women to reduce the risk of fractures. Additionally, it is used to prevent bone complications in patients with certain cancers, such as multiple myeloma and bone metastases.
Prolia 60mg Injection works by inhibiting a protein called RANK ligand, which is involved in the breakdown of bone tissue. By blocking this process, it helps increase bone density and strength. Clinical studies have shown that it can significantly improve bone health, reducing the chances of fractures in patients with osteoporosis and those with cancer-related bone loss.
Patients may need close monitoring of kidney function, especially if they have moderate renal impairment. The Prolia 60mg dosage should always be taken as directed by your doctor. If you are considering alternatives, your physician may suggest a suitable Prolia 60mg substitute depending on your condition.
When it comes to affordability and availability, patients often compare the Prolia 60mg injection price and the Prolia injection cost in India before starting treatment. Many reliable pharmacies allow you to buy Prolia 60mg online, making access more convenient. Reading Prolia injection reviews may also help patients understand the experiences of others undergoing this treatment. Prolia 60mg Injection Price in India varies by retailer and location.
View Complete details
Product Brochure
| Strength | 60 mg |
| Packaging Type | Pre-filled Syringe |
| Brand | Rozel |
| Manufacturer | Intas |
| Packaging Size | 1 ml |
| Storage Temperature | 2-8 degree c |
| Shelf Life | 36 month |
| Composition | Denosumab |
Rozel 60mg Injection contains the active ingredient denosumab and is used rozel for osteoporosis and to prevent bone complications in patients with cancer. Rozel injection uses include treating osteoporosis (to strengthen weakened bones) and managing bone loss related to cancers such as rozel injection for multiple myeloma and rozel injection for bone cancer (bone metastases). Rozel 60mg price varies by city, hospital and supplier, so check local pharmacies or your hospital for current rates.
Rozel works by inhibiting RANK ligand, a protein involved in bone breakdown, and studies have shown it can increase bone density and reduce fracture risk in postmenopausal women and patients with cancer-related bone loss. The exact rozel injection dosage and how to take rozel injection are determined by your oncologist or specialist (it is administered in a clinic and requires monitoring). In discussions of rozel vs prolia, both are denosumab-based products—differences are mostly brand, approved indications and cost—so talk to your doctor or pharmacist about which option is right for you.
View Complete details
Product Brochure
| Strength | 60 mg |
| Dose/Strength | 60 mg |
| Packaging Type | Box |
| Brand | Domvel 60mg |
| Packaging Size | 1 ml |
| Composition | Denosumab 60mg/ml |
| Country of Origin | Made in India |
| Marketer | Eris Lifescience ltd |
Domvel 60mg injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. It is also prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Domvel 60mg injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment.
Domvel 60mg injection should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required to ensure during the treatment. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels.
View Complete details
Product Brochure
| Strength | 60 mg |
| Dose/Strength | 60 mg |
| Packaging Type | Vial |
| Brand | Olimab |
| Packaging Size | 1 ml |
| Country of Origin | Made in India |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Salt Composition | Denosumab 60mg Injection |
Olimab Injection 60mg consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. Olimab injection uses in prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Olimab 60mg Injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment. Olimab 60 mg injection can be used to treat osteoporosis in postmenopausal women and men who are at high risk of fractures.
Olimab 60mg Injection should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required to ensure during the treatment. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels.
View Complete details
Product Brochure
| Strength | 120 mg |
| Dose/Strength | 120 mg |
| Packaging Type | Vial |
| Brand | Esentra |
| Packaging Size | 1 ml |
| Country of Origin | Made in India |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Salt Composition | Denosumab Injection |
Esentra 120mg Injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. It is also prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Denosumab works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment.
Esentra 120mg Injection should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required to ensure during the treatment. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels. Esentra 120 mg injection price varies by retailer and location.
View Complete details
Product Brochure
| Strength | 120 mg |
| Packaging Type | Vial |
| Brand | Denosurel |
| Manufacturer | RELIANCE LIFE SCIENCES PVT LTD |
| Packaging Size | 1 ml |
| Storage Temperature | 2-8 degree c |
| Shelf Life | 36 month |
| Composition | Denosumab |
Denosurel 120mg Injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. It is also prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Denosurel 120mg Injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment.
Denosurel 120mg Injection should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required to ensure during the treatment. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels.
View Complete details